Insmed Incorporated is a biopharmaceutical company focused on developing therapies for serious diseases, particularly orphan diseases and chronic lung infections. The company operates in the biotechnology sector and is engaged in research and development of pharmaceuticals. Insmed serves patients in the United States, Europe, and Japan, with a specific emphasis on conditions such as non-cystic fibrosis bronchiectasis and nontuberculous mycobacterial lung disease.
